AISAP Secures $13M in Seed Funding to Revolutionize Ultrasound Diagnostics with AI.
AISAP specializes in enhancing medical ultrasound diagnostics through AI technology, aiming to make advanced imaging more accessible and accurate, especially with portable devices.
Company Name: AISAP
Location: Tel Aviv, Israel
Sector: Medical Technology
Funding Details: Raised $13M in Seed funding led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P.
Purpose of Investment: To expand operations and development efforts.
Leadership: Led by CEO Roni Attali, with co-founders Adiel Am-Shalom, Ehud Raanani, Robert Klempfner, and Ehud Schwammenthal.
Product: AISAP provides a Point of Care Assisted Diagnosis (POCAD)™ solution for the medical ultrasound industry. The AI-powered platform offers features such as an "urgency score" to prioritize cases, a scan quality score for operator accuracy, and deep learning AI for enhanced image interpretation.
About Company: AISAP specializes in enhancing medical ultrasound diagnostics through AI technology, aiming to make advanced imaging more accessible and accurate, especially with portable devices.
